MedTrace Logo

Non-invasive Test for Acute Rejection Identification in Heart Transplanted Patients

NCT04274712 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2020-02-18

No results posted yet for this study

Summary

Aim of the study is to test INNOGRAFT Heart Suite in a clinical setting, using a previously collected set of plasma samples from patients who underwent heart transplant and routinely or symptoms-based surveillance during the period 2016- 2019.

Conditions

  • Acute Rejection of Cardiac Transplant

Interventions

DIAGNOSTIC_TEST

INNOGRAFT Heart Suite

Liquid biopsy to identify acute rejection

Sponsors & Collaborators

  • Fondazione IRCCS Policlinico San Matteo di Pavia

    collaborator OTHER

  • Istituto Di Ricerche Farmacologiche Mario Negri

    collaborator OTHER

  • Myway Gentics Srl

    lead INDUSTRY

Principal Investigators

  • Valentina Favalli, PhD · Myway Gentics Srl

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-03
Primary Completion
2020-06-30
Completion
2020-09-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04274712 on ClinicalTrials.gov